Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

PKC alpha expression is a marker for breast cancer aggressiveness

Kalstad Lönne, Gry LU ; Cornmark, Louise LU ; Zahirovic, Iris Omanovic ; Landberg, Göran LU ; Jirström, Karin LU orcid and Larsson, Christer LU (2010) In Molecular Cancer 9.
Abstract
Background: Protein kinase C (PKC) isoforms are potential targets for breast cancer therapy. This study was designed to evaluate which PKC isoforms might be optimal targets for different breast cancer subtypes. Results: In two cohorts of primary breast cancers, PKC alpha levels correlated to estrogen and progesterone receptor negativity, tumor grade, and proliferative activity, whereas PKC delta and PKC epsilon did not correlate to clinicopathological parameters. Patients with PKC alpha-positive tumors showed poorer survival than patients with PKC alpha-negative tumors independently of other factors. Cell line studies demonstrated that PKC alpha levels are high in MDA-MB-231 and absent in T47D cells which proliferated slower than other... (More)
Background: Protein kinase C (PKC) isoforms are potential targets for breast cancer therapy. This study was designed to evaluate which PKC isoforms might be optimal targets for different breast cancer subtypes. Results: In two cohorts of primary breast cancers, PKC alpha levels correlated to estrogen and progesterone receptor negativity, tumor grade, and proliferative activity, whereas PKC delta and PKC epsilon did not correlate to clinicopathological parameters. Patients with PKC alpha-positive tumors showed poorer survival than patients with PKC alpha-negative tumors independently of other factors. Cell line studies demonstrated that PKC alpha levels are high in MDA-MB-231 and absent in T47D cells which proliferated slower than other cell lines. Furthermore, PKC alpha silencing reduced proliferation of MDA-MB-231 cells. PKC alpha inhibition or downregulation also reduced cell migration in vitro. Conclusions: PKC alpha is a marker for poor prognosis of breast cancer and correlates to and is important for cell functions associated with breast cancer progression. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Molecular Cancer
volume
9
publisher
BioMed Central (BMC)
external identifiers
  • wos:000278310000001
  • scopus:77953479806
  • pmid:20398285
ISSN
1476-4598
DOI
10.1186/1476-4598-9-76
language
English
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Pathology (Malmö) (013031000), Tumour Cell Biology (013017530), Pathology, (Lund) (013030000)
id
872ee021-c4dd-4b43-be9f-a42e2b180e05 (old id 1631795)
date added to LUP
2016-04-01 14:04:22
date last changed
2024-01-29 02:54:33
@article{872ee021-c4dd-4b43-be9f-a42e2b180e05,
  abstract     = {{Background: Protein kinase C (PKC) isoforms are potential targets for breast cancer therapy. This study was designed to evaluate which PKC isoforms might be optimal targets for different breast cancer subtypes. Results: In two cohorts of primary breast cancers, PKC alpha levels correlated to estrogen and progesterone receptor negativity, tumor grade, and proliferative activity, whereas PKC delta and PKC epsilon did not correlate to clinicopathological parameters. Patients with PKC alpha-positive tumors showed poorer survival than patients with PKC alpha-negative tumors independently of other factors. Cell line studies demonstrated that PKC alpha levels are high in MDA-MB-231 and absent in T47D cells which proliferated slower than other cell lines. Furthermore, PKC alpha silencing reduced proliferation of MDA-MB-231 cells. PKC alpha inhibition or downregulation also reduced cell migration in vitro. Conclusions: PKC alpha is a marker for poor prognosis of breast cancer and correlates to and is important for cell functions associated with breast cancer progression.}},
  author       = {{Kalstad Lönne, Gry and Cornmark, Louise and Zahirovic, Iris Omanovic and Landberg, Göran and Jirström, Karin and Larsson, Christer}},
  issn         = {{1476-4598}},
  language     = {{eng}},
  publisher    = {{BioMed Central (BMC)}},
  series       = {{Molecular Cancer}},
  title        = {{PKC alpha expression is a marker for breast cancer aggressiveness}},
  url          = {{http://dx.doi.org/10.1186/1476-4598-9-76}},
  doi          = {{10.1186/1476-4598-9-76}},
  volume       = {{9}},
  year         = {{2010}},
}